Spatial Relation Between White Matter Hyperintensities and Incident Lacunes of Presumed Vascular Origin: A 14-Year Follow-Up Study
- PMID: 36189679
- PMCID: PMC9698104
- DOI: 10.1161/STROKEAHA.122.039903
Spatial Relation Between White Matter Hyperintensities and Incident Lacunes of Presumed Vascular Origin: A 14-Year Follow-Up Study
Abstract
Background: The underlying mechanisms of incident lacunes regarding their spatial distribution remain largely unknown. We investigated the spatial distribution pattern and MRI predictors of incident lacunes in relation to white matter hyperintensity (WMH) over 14 years follow-up in sporadic small vessel disease.
Methods: Five hundred three participants from the ongoing prospective single-center Radboud University Nijmegen Diffusion Tensor and Magnetic resonance Cohort (RUN DMC) were recruited with baseline assessment in 2006 and follow ups in 2011, 2015, and 2020. Three hundred eighty-two participants who underwent at least 2 available brain MRI scans were included. Incident lacunes were systematically identified, and the spatial relationship between incident lacunes located in subcortical white matter and WMH were determined using a visual rating scale. Adjusted multiple logistic regression and linear mixed-effect regression models were used to assess the association between baseline small vessel disease markers, WMH progression, and incident lacunes. Participants with atrial fibrillation were excluded in multivariable analysis.
Results: Eighty incident lacunes were identified in 43 patients (mean age 66.5±8.2 years, 37.2% women) during a mean follow-up time of 11.2±3.3 years (incidence rate 10.0/1000 person-year). Sixty percent of incident lacunes were in the white matter, of which 48.9% showed no contact with preexisting WMH. Baseline WMH volume (odds ratio=2.5 [95% CI, 1.6-4.2]) predicted incident lacunes after adjustment for age, sex, and vascular risk factors. WMH progression was associated with incident lacunes independent of age, sex, baseline WMH volume, and vascular risk factors (odds ratio, 3.2 [95% CI, 1.5-6.9]). Baseline WMH volume and progression rate were higher in participants with incident lacunes in contact with preexisting WMH. No difference in vascular risk factors was observed regarding location or relation with preexisting WMH.
Conclusions: The 2 different distribution patterns of lacunes regarding their relation to WMH may suggest distinct underlying mechanisms, one of which may be more closely linked to a similar pathophysiology as that of WMH. The longitudinal relation between WMH and lacunes further supports plausible shared mechanisms between the 2 key markers.
Keywords: incident lacunes; magnetic resonance imaging; small vessel disease; spatial distribution; white matter hyperintensities.
Figures



Similar articles
-
Determinants and Temporal Dynamics of Cerebral Small Vessel Disease: 14-Year Follow-Up.Stroke. 2022 Sep;53(9):2789-2798. doi: 10.1161/STROKEAHA.121.038099. Epub 2022 May 4. Stroke. 2022. PMID: 35506383 Free PMC article.
-
Nonlinear temporal dynamics of cerebral small vessel disease: The RUN DMC study.Neurology. 2017 Oct 10;89(15):1569-1577. doi: 10.1212/WNL.0000000000004490. Epub 2017 Sep 6. Neurology. 2017. PMID: 28878046 Free PMC article.
-
Progression of white matter hyperintensities and incidence of new lacunes over a 3-year period: the Leukoaraiosis and Disability study.Stroke. 2008 May;39(5):1414-20. doi: 10.1161/STROKEAHA.107.498535. Epub 2008 Mar 6. Stroke. 2008. PMID: 18323505
-
Longitudinal Changes of White Matter Hyperintensities in Sporadic Small Vessel Disease: A Systematic Review and Meta-analysis.Neurology. 2022 Nov 29;99(22):e2454-e2463. doi: 10.1212/WNL.0000000000201205. Epub 2022 Sep 19. Neurology. 2022. PMID: 36123130 Free PMC article.
-
White matter hyperintensities and risks of cognitive impairment and dementia: A systematic review and meta-analysis of 36 prospective studies.Neurosci Biobehav Rev. 2021 Jan;120:16-27. doi: 10.1016/j.neubiorev.2020.11.007. Epub 2020 Nov 11. Neurosci Biobehav Rev. 2021. PMID: 33188821
Cited by
-
CT Perfusion in Lacunar Stroke: A Systematic Review.Diagnostics (Basel). 2023 Apr 27;13(9):1564. doi: 10.3390/diagnostics13091564. Diagnostics (Basel). 2023. PMID: 37174955 Free PMC article. Review.
-
Baseline and Longitudinal MRI Markers Associated With 16-Year Mortality in Patients With Cerebral Small Vessel Disease.Neurology. 2024 Sep 24;103(6):e209701. doi: 10.1212/WNL.0000000000209701. Epub 2024 Aug 21. Neurology. 2024. PMID: 39167750 Free PMC article.
-
The pathogenesis of cerebral small vessel disease and vascular cognitive impairment.Physiol Rev. 2025 Jul 1;105(3):1075-1171. doi: 10.1152/physrev.00028.2024. Epub 2025 Feb 18. Physiol Rev. 2025. PMID: 39965059 Free PMC article. Review.
References
-
- Wardlaw JM, Smith EE, Biessels GJ, Cordonnier C, Fazekas F, Frayne R, Lindley RI, O’Brien JT, Barkhof F, Benavente OR., et al. . Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration. Lancet Neurol. 2013;12:822–838. doi: 10.1016/S1474-4422(13)70124-8 - PMC - PubMed
-
- van Dijk EJ, Prins ND, Vrooman HA, Hofman A, Koudstaal PJ, Breteler MM. Progression of cerebral small vessel disease in relation to risk factors and cognitive consequences: rotterdam scan study. Stroke. 2008;39:2712–2719. doi: 10.1161/STROKEAHA.107.513176 - PubMed
-
- van Leijsen EMC, Kuiperij HB, Kersten I, Bergkamp MI, van Uden IWM, Vanderstichele H, Stoops E, Claassen J, van Dijk EJ, de Leeuw FE., et al. . Plasma abeta (amyloid-beta) levels and severity and progression of small vessel disease. Stroke. 2018;49:884–890. doi: 10.1161/STROKEAHA.117.019810 - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources